Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Eolus Vind B | 7EVB | 22. nov 2024 | 3.94 | -0.63 |
EPAM Systems, Inc. | E3M | 22. nov 2024 | 234.80 | +0.64 |
EPE Special Opportunities Limited | EP0 | 22. nov 2024 | 1.81 | -1.63 |
EPENDION AB SK 0,3333 | TW4 | 22. nov 2024 | 8.03 | +1.13 |
Epigenomics AG | ECX | 22. nov 2024 | 1.20 | +20.00 |
Epiroc A | 3AD1 | 22. nov 2024 | 16.81 | +0.39 |
EPIROC AB UNSP.ADR/1 | 3ADA | 22. nov 2024 | 16.40 | 0.00 |
Epiroc B | 3AD2 | 22. nov 2024 | 15.20 | +0.13 |
Episurf Medical B | 16E | 22. nov 2024 | 0.00 | -3.23 |
ePlay Digital Inc | 2NY2 | 22. nov 2024 | 0.00 | 0.00 |
ePlus inc. | MLE | 22. nov 2024 | 76.00 | -0.65 |
EPR Properties | E2H | 22. nov 2024 | 42.79 | +2.38 |
EPRCOMUNICAZIONE S.P.A. | J3P | 22. nov 2024 | 1.05 | -0.94 |
EPTI AB AK | G7H0 | 22. nov 2024 | 1.71 | 0.00 |
Epwin Group Plc | 2E3 | 22. nov 2024 | 1.22 | 0.00 |
EQB INC. | V22 | 22. nov 2024 | 74.50 | +1.36 |
EQL Pharma | 7JK | 22. nov 2024 | 5.74 | +2.50 |
EQT | 6EQ | 22. nov 2024 | 26.35 | +4.23 |
EQT Corporation | EQ6 | 22. nov 2024 | 45.24 | -0.12 |
Eqtec | KEU | 22. nov 2024 | 0.01 | 0.00 |
Equals Group Plc | 2FX | 22. nov 2024 | 1.39 | -0.71 |
Equatorial Resources Limited | PBU | 22. nov 2024 | 0.06 | +2.75 |
Equifax, Inc. | EFX | 22. nov 2024 | 240.00 | +2.56 |
Equillium, Inc. | 0FY | 22. nov 2024 | 0.66 | +4.26 |
Equinix, Inc. | EQN2 | 22. nov 2024 | 899.00 | +3.69 |
Equinor | DNQ | 22. nov 2024 | 23.59 | -1.52 |
Equinor ASA | DNQA | 22. nov 2024 | 23.50 | -0.42 |
Equinox Gold Corp | 1LRC | 22. nov 2024 | 5.49 | +3.00 |
EQUIPMAKE HLDGS LS -,0001 | U8O | 22. nov 2024 | 0.03 | 0.00 |
Equitable Holdings Inc | AXJ | 22. nov 2024 | 44.00 | +0.92 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.